ETF Managers Group, LLC Enochian Biosciences Inc Transaction History

ETF Managers Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.7 - $2.86 $1,876 - $3,157	-1,104 Reduced 6.6%	15,625 $28,000
Q2 2022 Aug 15, 2022	BUY	$1.93 - $8.73 $1,474 - $6,669	764 Added 4.79%	16,729 $40,000
Q1 2022 May 13, 2022	BUY	$4.42 - $9.0 $804 - $1,638	182 Added 1.15%	15,965 $129,000
Q4 2021 Feb 14, 2022	SELL	$6.71 - $12.55 $20,566 - $38,465	-3,065 Reduced 16.26%	15,783 $117,000
Q3 2021 Nov 15, 2021	BUY	$4.56 - $7.88 $21,655 - $37,422	4,749 Added 33.68%	18,848 $126,000
Q2 2021 Aug 16, 2021	SELL	$2.94 - $6.79 $646 - $1,493	-220 Reduced 1.54%	14,099 $72,000
Q1 2021 May 17, 2021	SELL	$3.02 - $4.51 $25,262 - $37,726	-8,365 Reduced 36.88%	14,319 $47,000
Q4 2020 Feb 16, 2021	SELL	$2.82 - $3.55 $10,355 - $13,035	-3,672 Reduced 13.93%	22,684 $73,000
Q3 2020 Nov 16, 2020	BUY	$3.42 - $4.55 $90,137 - $119,919	26,356 New	26,356 $98,000

14M

33.7K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.